Featured Posts
News Release
Rescheduling marijuana to a less restrictive category will benefit liberty and public health
President Trump signed an executive order today intended to fast track the rescheduling of cannabis from a Schedule I substance, the same as heroin,…
News Release
CEI Study: Government laws against pharmacy ownership would increase costs, restrict access for consumers
Innovation is reshaping how Americans get their prescription medications. Whether picking up medications in person, ordering online, or getting same-day delivery from services like Capsule,…
National Review
RFK Jr.’s Cherry-Picked Science
One of Robert F. Kennedy Jr.’s promises as secretary of health and human services was to bring gold-standard science to our public…
Search Posts
Blog
Department of Health and Human Services Needs to Correct Record on Marijuana
Regulators at the federal Drug Enforcement Agency (DEA) had an opportunity in 2016 to move marijuana into a less restrictive category of controlled substances. This…
Blog
Trump Administration Ends Homecare Providers Dues Skim
Since 2000, state governments have diverted $1.4 billion from homecare providers and handed it to labor unions, according to the Freedom Foundation. For over a…
News Release
McConnell Plan to Raise Nicotine Access to Age 21 Could Backfire
Citing health concerns about youth vaping, Senate Majority Leader Mitch McConnell (R-Kentucky) announced legislation to raise the nationwide minimum age to buy tobacco products from…
Medium
The FDA’s Runaway Trolley Problem
If you’ve ever participated in a thought experiment, you know how fun that can be. The most famous is the Trolley Problem, entertainingly portrayed by…
American Chemistry
IRIS: Bad Science, Real World Consequences
American Chemistry cited CEI’s publication by Senior Fellow Angela Logomasini on the IRIS. In February 2019 the Competitive Enterprise Institute (CEI) provided some important…
Comment
CEI Comments to FDA on Modifications to Compliance Policy for Certain Deemed Tobacco Products
Dear Dr. Gottlieb: The Competitive Enterprise Institute (CEI) welcomes the opportunity to offer the following comments on the Food and Drug Administration’s (FDA) proposed modifications…